https://www.selleckchem.com/products/b-ap15.html
The major challenge associated with the use of OMVs is its fragile structure and stability. However, a particulate form of the vaccine could be a suitable delivery system that can protect the antigen from degradation by a harsh acidic or enzymatic environment. The particulate form of the vaccine can also act as an adjuvant by itself. This review will highlight some practical methods for formulating microparticulate OMV-based vaccines for STDs.Malaria is a life-threatening global epidemic disease and has caused more than 400,000 deaths in
Like
Comment
Share
